Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
Ono M, Onuma Y, Kawashima H, Hara H, Gao C, Wang R, O'Leary N, Benit E, Janssens L, Ferrario M, Żurakowski A, Dominici M, Huber K, Buszman P, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Windecker S, Vranckx P, Deliargyris EN, Bhatt DL, Storey RF, Valgimigli M, Serruys PW; GLOBAL LEADERS trial investigators.
Ono M, et al.
Catheter Cardiovasc Interv. 2022 Jul;100(1):72-82. doi: 10.1002/ccd.30217. Epub 2022 May 2.
Catheter Cardiovasc Interv. 2022.
PMID: 35500171
Free PMC article.
Clinical Trial.